FDA is alerting patients and health care professionals to Pfizer’s voluntary recall of nine lots of the smoking cessation drug, varenicline (brand name Chantix), to the warehouse level.
Pfizer Inc. announced today results from a Phase 4 study evaluating the efficacy and safety of CHANTIX®/CHAMPIX®(varenicline) for smoking cessation in nicotine dependent adolescents 12-19 years of age.